Suggestions
Journal Information
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
123
Full text access

ASSESSMENT OF THE PREVALENCE OF GERIATRIC SYNDROMES IN A COHORT OF OLDER PEOPLE LIVING WITH HIV/AIDS

Visits
127
Giovanna Haimowski
Corresponding author
giovannahaimowski@hotmail.com

Corresponding author.
, Aline Barnabé Cano, Ana Caroline Coutinho Iglessias, Camila de Albuquerque Moraes, Cintia Dellaqua, Lucas Rocker Ramos, Lucas de Souza Loureiro Abbud Santos, Luciene Silva Arrifano, Patrícia Rady Müller, Priscilla de Lima e Menezes, Victoria Spinola Duarte de Oliveira, José Valdez Ramalho Madruga, Roberta Schiavon Nogueira
Centro de Referência e Treinamento DST/AIDS, São Paulo, SP, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 30. Issue S1

XXIV Brazilian Congress of Infectious Diseases 2025

More info
Introduction/Objectives

Geriatric syndromes (GSs) are clinical conditions frequently observed in older adults, resulting from interactions among physical, psychological, and social factors. They are not classified as specific diseases but are associated with functional decline, loss of autonomy, and reduced quality of life. Among people living with HIV/AIDS (PLWHA), multifactorial conditions related to aging may accelerate the onset of GSs, affecting morbidity, mortality, and healthcare demand. This study aimed to evaluate the prevalence of GSs in a cohort of PLWHA aged ≥ 50 years.

Methods

Cross-sectional study using baseline data from a cohort of PLWHA aged ≥ 50 years, including both ART-naïve individuals and those under viral suppression. Data were collected via REDCap. Evaluated GSs included: frailty, measured by Fried phenotype (≥ 1 classified as pre-frail/frail); sarcopenia, defined as body mass index (BMI) < 19 and/or Short Physical Performance Battery (SPPB) score ≤ 9; and neurocognitive impairment, assessed by Montreal Cognitive Assessment (MoCA) < 26. Hospitalization and falls in the last 12 months were analyzed, as well as polypharmacy (≥ 5 medications) and extreme polypharmacy (≥ 10 medications), excluding ART.

Results

Thirty-seven PLWHA were included (7 ART-naïve and 30 under viral suppression). Median age was 61 years; 86% were cisgender men and 51% were mixed-race/Black. Median CD4 T-cell count was 667 cells/mm³, CD4/CD8 ratio 0.93, and nadir 271 cells/mm³. Among those under viral suppression, median infection duration was 20 years, 67% had been on ART ≥10 years, and median BMI was 26 kg/m². Overall prevalence of GSs was 95%, with 81% of participants presenting two or more GSs. Frailty/pre-frailty was found in 41%; low physical performance in 68%, suggesting sarcopenia; probable neurocognitive impairment in 62%, with severe cases (MoCA < 21) in 19%. Hospitalization and fall rates were 8% and 11%, respectively. Polypharmacy occurred in 65%, and extreme polypharmacy in 38%.

Conclusion

The high prevalence of GSs and polypharmacy underscores the need for care models tailored to older PLWHA. As the number of older adults with HIV continues to grow, integrating geriatric assessments into care pathways is essential to identify vulnerabilities and provide individualized interventions that improve quality of life.

Keywords:
Geriatric syndromes
Aging
HIV/AIDS
Frailty
Polypharmacy
Full text is only available in PDF
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools